Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2024 ∙ Wyse, C. A. Rudderham, L. M. Nordon, E. A. Ince, L. M. Coogan, A. N. Lopez, L. M.

Circadian Variation in the Response to Vaccination: A Systematic Review and Evidence Appraisal

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.

Common characteristics of shoulder injury related to vaccine administration following COVID-19 vaccination: a comprehensive systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Limbu, Y. B. McKinley, C.

Communication strategies to promote covid-19 vaccination intention: How effective are source, appeal, framing, and evidence type approaches?

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Liao, X. Lin, M. Yang, L. Cheung, K. Zhang, Q. Li, Y. Hao, C. Wang, H. H. Gao, Y. Zhang, D. D. Molassiotis, A. Siu, G. K. H. Man Leung, A. Y. Xie, Y. J.

Community engagement in vaccination promotion: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Kavikondala, S. Haeussler, K. Wang, X. Bausch-Jurken, M. T. Nassim, M. Mishra, N. K. Malmenäs, M. Sharma, P. Van de Velde, N. Green, N. Beck, E.

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wu, X. Xu, K. Zhan, P. Liu, H. Zhang, F. Song, Y. Lv, T.

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ San Francisco Ramos, A. Liu Sanchez, C. Bovill Rose, T. Smith, D. Thorn, N. Galiza, E. Miah, T. Pearce, J. Hultin, C. Cosgrove, C. Hsia, Y. Heath, P. T.

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Zeng, Y. Du, Z. Shao, C. Zhao, M.

Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Chamani, I. J. Taylor, L. L. Dadoun, S. E. McKenzie, L. J. Detti, L. Ouellette, L. McCulloh, D. H. Licciardi, F. L.

Coronavirus Disease 2019 (COVID-19) Vaccination and Assisted Reproduction Outcomes: A Systematic Review and Meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Zhang, Q. Jiao, L. Chen, Q. Bulstra, C. A. Geldsetzer, P. de Oliveira, T. Yang, J. Wang, C. Barnighausen, T. Chen, S.

COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...